![](/img/cover-not-exists.png)
A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
Jameson, G. S., Hamm, J. T., Weiss, G. J., Alemany, C., Anthony, S., Basche, M., Ramanathan, R. K., Borad, M. J., Tibes, R., Cohn, A., Hinshaw, I., Jotte, R., Rosen, L. S., Hoch, U., Eldon, M. A., MedVolume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-1201
Date:
January, 2013
File:
PDF, 570 KB
english, 2013